Insider Cluster (4 insiders) ·Filed May 5, 2026

CYTK

CYTOKINETICS INC
MIXED
Impact 4/10
Horizondays Processed5mo ago
Insider cluster: 4 insiders, $4.5M total
Actionable Insight ◆ Mixed

Monitor for continued insider selling in coming weeks; while the cluster is small, insider activity at earnings time often signals near-term profit-taking. The positive launch data supports the stock, but further sales from executives could weigh on sentiment.

DirectionMixed
Confidencehigh
Horizondays
Final — all horizons settled through T+60d ⚠ clustered
CYTK ▲ +4.32% at T+60d
NEUTRAL call ✓ call won +4.32% · α vs SPY +1.58% · entry $77.09 → $80.42
Entry anchored
May 4, 03:59 PM ET
via exchange tick
T+1d
-2.92%
call -2.92% · α -4.30%
$74.84
settled 5mo ago
T+5d
-3.28%
call -3.28% · α -5.27%
$74.56
settled 5mo ago
T+20d
-8.02%
call -8.02% · α -12.97%
$70.91
settled 4mo ago
T+60d
+4.32%
call +4.32% · α +1.58%
$80.42
settled 2mo ago

Price Chart

Loading chart...

Executive Summary

Multiple CYTK insiders, including CFO and CCO, sold shares totaling $4.53M on the same day as Q1 2026 earnings release showing strong MYQORZO launch. The cluster is small relative to market cap (0.055%) but notable for involving key executives and timing with positive news.

Key Financial Metrics

Direction
selling
Total Value
$4.5M
Insiders
4

Key Facts

  • 4 insiders sold shares on May 5, 2026, including CFO Lee Sung ($1.84M) and CCO Andrew Callos ($875K)
  • Total open-market sales: $4.53M, representing 0.055% of $8.2B market cap
  • Sales occurred on same day as Q1 earnings: MYQORZO launch revenue $4.8M, ACACIA-HCM trial positive
  • Directors Henderson and Wierenga also sold shares alongside derivative exercises

Financial Impact

Insiders sold $4.53M in open-market transactions, ~0.055% of market cap

insider selling

Risk Factors

  • Further insider selling could dampen investor sentiment
  • Commercial execution of MYQORZO launch may face headwinds
  • Regulatory or safety issues with aficamten in nHCM

Market Snapshot

Exchange
Nasdaq
Sector
Pharmaceutical Preparations
Analyst Consensus
85% bullish (27 analysts)

Investment Themes

Biotech & Drug Discovery

Documents Analyzed

This report is based on 1 SEC document filed with EDGAR.

DocumentAccession Number
CLUSTER Data (Synthetic)cluster-CYTK-1778012475448
32 reports for CYTK
Performance horizon
89% Hit rate 8 of 9 directional calls best @ T+20▲ +10.38%Mar 31, 2026
Filters
Rows
Reports for CYTK — sortable, filterable
TypeNow
Sep 15, 2026
17d ago
Insider Cluster
BEARISH ★ 5/10
$69.31 $67.59▲ +2.48%▲ +4.59%$65.60 (+5.35%)
Sep 11, 2026
20d ago
Insider Cluster
NEUTRAL ★ 2/10
$72.45 $67.56▼ −6.75%▼ −6.86%$65.60 (−9.45%)
Sep 1, 2026
4w ago
Insider Cluster
NEUTRAL ★ 2/10
$71.40 $74.11▲ +3.80%▲ +3.71%$65.60 (−8.12%)
Aug 31, 2026
4w ago
Insider Cluster
NEUTRAL ★ 3/10
$71.40 $74.11▲ +3.80%▲ +3.71%$65.60 (−8.12%)
Aug 29, 2026
4w ago
Press Release
BULLISH ★ 7/10
$70.91 $75.35▲ +6.26%▲ +6.40%$65.60 (−7.49%)
Aug 28, 2026
5w ago
8-K
BULLISH ★ 7/10
$72.09 $72.72▲ +0.87%▲ +0.76%$65.60 (−9.00%)
Jul 30, 2026
9w ago
Insider Cluster
NEUTRAL ★ 2/10
$80.42 $81.37▲ +1.18%▼ −2.44%$65.60 (−18.43%)
Jul 27, 2026
9w ago
Insider Cluster
NEUTRAL ★ 2/10
$80.62 $77.13▼ −4.33%▼ −5.40%$65.60 (−18.63%)
Jul 23, 2026
10w ago
Press Release
NEUTRAL ★ 2/10
$80.74 $80.42▼ −0.40%▼ −0.77%$65.60 (−18.75%)
Jul 14, 2026
11w ago
Insider Cluster
NEUTRAL ★ 2/10
$81.93 $79.11▼ −3.44%▼ −2.15%$65.60 (−19.93%)
Showing 10 of 32

US Market Status

Market Closed — Opens Mon (65h 8m)

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Try SecBot Free Coming soon: SecBot Pro with alerts, watchlists, and API access
Report published May 5, 2026